These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sulforhodamine B assay and chemosensitivity. Voigt W Methods Mol Med; 2005; 110():39-48. PubMed ID: 15901925 [TBL] [Abstract][Full Text] [Related]
3. Sulforhodamine B colorimetric assay for cytotoxicity screening. Vichai V; Kirtikara K Nat Protoc; 2006; 1(3):1112-6. PubMed ID: 17406391 [TBL] [Abstract][Full Text] [Related]
4. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma. Haselsberger K; Peterson DC; Thomas DG; Darling JL Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008 [TBL] [Abstract][Full Text] [Related]
5. Optimization of the sulforhodamine B colorimetric assay. Papazisis KT; Geromichalos GD; Dimitriadis KA; Kortsaris AH J Immunol Methods; 1997 Oct; 208(2):151-8. PubMed ID: 9433470 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents. Fricker SP; Buckley RG Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253 [TBL] [Abstract][Full Text] [Related]
7. Colorimetric chemosensitivity testing using sulforhodamine B. Kubota T; Takahara T; Nagata M; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M J Surg Oncol; 1993 Feb; 52(2):83-8. PubMed ID: 8468977 [TBL] [Abstract][Full Text] [Related]
8. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Perez RP; Godwin AK; Handel LM; Hamilton TC Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340 [TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137 [TBL] [Abstract][Full Text] [Related]
11. Key considerations when using the sulforhodamine B assay for screening novel anticancer agents. Shakil MS; Rana Z; Hanif M; Rosengren RJ Anticancer Drugs; 2022 Jan; 33(1):6-10. PubMed ID: 34261912 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124 [TBL] [Abstract][Full Text] [Related]
14. A rapid naphthol yellow S method for measuring the cellular protein content of anchorage cultures. Skehan P; Friedman SJ In Vitro Cell Dev Biol; 1985 May; 21(5):288-90. PubMed ID: 4019357 [TBL] [Abstract][Full Text] [Related]
15. [Cell culture and its application--in vitro evaluation of anticancer activity using human tumor cell lines]. Tashiro T Gan To Kagaku Ryoho; 1992 Oct; 19(12):2107-12. PubMed ID: 1329672 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. Monks A; Scudiero D; Skehan P; Shoemaker R; Paull K; Vistica D; Hose C; Langley J; Cronise P; Vaigro-Wolff A J Natl Cancer Inst; 1991 Jun; 83(11):757-66. PubMed ID: 2041050 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs. Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928 [TBL] [Abstract][Full Text] [Related]
19. An organoid culture assay (OCA) for determining the drug sensitivity of human tumors. Köpf-Maier P; Kolon B Int J Cancer; 1992 Apr; 51(1):99-107. PubMed ID: 1563848 [TBL] [Abstract][Full Text] [Related]
20. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Kobayashi H; Higashiyama M; Minamigawa K; Tanisaka K; Takano T; Yokouchi H; Kodama K; Hata T Jpn J Cancer Res; 2001 Feb; 92(2):203-10. PubMed ID: 11223550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]